ID   BLH1_YEAST              Reviewed;         483 AA.
AC   Q01532; D6W0V4;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 3.
DT   22-JUL-2015, entry version 155.
DE   RecName: Full=Cysteine proteinase 1, mitochondrial;
DE            EC=3.4.22.40;
DE   AltName: Full=Bleomycin hydrolase;
DE            Short=BLM hydrolase;
DE   AltName: Full=Homocysteine-thiolactonase;
DE            Short=HTLase;
DE            Short=Hcy-thiolactonase;
DE   AltName: Full=Leucine aminopeptidase 3;
DE   AltName: Full=Y3;
DE   Flags: Precursor;
GN   Name=LAP3; Synonyms=BLH1, GAL6, YCP1; OrderedLocusNames=YNL239W;
GN   ORFNames=N1118;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=1400467;
RA   Kambouris N.G., Burke D.J., Creutz C.E.;
RT   "Cloning and characterization of a cysteine proteinase from
RT   Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 267:21570-21576(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 228-250 AND
RP   367-387.
RX   PubMed=8424954; DOI=10.1016/0167-4781(93)90069-P;
RA   Magdolen U., Mueller G., Magdolen V., Bandlow W.;
RT   "A yeast gene (BLH1) encodes a polypeptide with high homology to
RT   vertebrate bleomycin hydrolase, a family member of thiol
RT   proteinases.";
RL   Biochim. Biophys. Acta 1171:299-303(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=8463237;
RA   Enenkel C., Wolf D.H.;
RT   "BLH1 codes for a yeast thiol aminopeptidase, the equivalent of
RT   mammalian bleomycin hydrolase.";
RL   J. Biol. Chem. 268:7036-7043(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8896273;
RX   DOI=10.1002/(SICI)1097-0061(199609)12:10B<1071::AID-YEA4>3.3.CO;2-J;
RA   Pandolfo D., de Antoni A., Lanfranchi G., Valle G.;
RT   "The DNA sequence of cosmid 14-5 from chromosome XIV reveals 21 open
RT   reading frames including a novel gene encoding a globin-like domain.";
RL   Yeast 12:1071-1076(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169873;
RA   Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K.,
RA   Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K.,
RA   Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M.,
RA   Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F.,
RA   Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F.,
RA   Doignon F., Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M.,
RA   Fritz C., Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N.,
RA   Goffeau A., Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D.,
RA   Hilbert H., Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A.,
RA   Jonniaux J.-L., Karpfinger-Hartl L., Lanfranchi G., Lepingle A.,
RA   Levesque H., Lyck R., Maftahi M., Mallet L., Maurer C.T.C.,
RA   Messenguy F., Mewes H.-W., Moestl D., Nasr F., Nicaud J.-M.,
RA   Niedenthal R.K., Pandolfo D., Pierard A., Piravandi E., Planta R.J.,
RA   Pohl T.M., Purnelle B., Rebischung C., Remacha M.A., Revuelta J.L.,
RA   Rinke M., Saiz J.E., Sartorello F., Scherens B., Sen-Gupta M.,
RA   Soler-Mira A., Urbanus J.H.M., Valle G., Van Dyck L., Verhasselt P.,
RA   Vierendeels F., Vissers S., Voet M., Volckaert G., Wach A.,
RA   Wambutt R., Wedler H., Zollner A., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV
RT   and its evolutionary implications.";
RL   Nature 387:93-98(1997).
RN   [6]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58, MASS SPECTROMETRY, AND
RP   MUTAGENESIS OF CYS-102 AND 271-LYS--LYS-274.
RX   PubMed=9374524; DOI=10.1074/jbc.272.48.30350;
RA   Zheng W., Xu H.E., Johnston S.A.;
RT   "The cysteine-peptidase bleomycin hydrolase is a member of the
RT   galactose regulon in yeast.";
RL   J. Biol. Chem. 272:30350-30355(1997).
RN   [8]
RP   PROTEIN SEQUENCE OF 228-251 AND 367-387.
RX   PubMed=1882548; DOI=10.1002/yea.320070305;
RA   Creutz C.E., Snyder S.L., Kambouris N.G.;
RT   "Calcium-dependent secretory vesicle-binding and lipid-binding
RT   proteins of Saccharomyces cerevisiae.";
RL   Yeast 7:229-244(1991).
RN   [9]
RP   PROTEIN SEQUENCE OF C-TERMINUS, X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS)
RP   OF 30-483, AND SUBUNIT.
RX   PubMed=7638617; DOI=10.1126/science.7638617;
RA   Joshua-Tor L., Xu H.E., Johnston S.A., Rees D.C.;
RT   "Crystal structure of a conserved protease that binds DNA: the
RT   bleomycin hydrolase, Gal6.";
RL   Science 269:945-950(1995).
RN   [10]
RP   DNA-BINDING, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8063738;
RA   Xu H.E., Johnston S.A.;
RT   "Yeast bleomycin hydrolase is a DNA-binding cysteine protease.
RT   Identification, purification, biochemical characterization.";
RL   J. Biol. Chem. 269:21177-21183(1994).
RN   [11]
RP   DNA-BINDING, AND SUBCELLULAR LOCATION.
RX   PubMed=9584198;
RA   Zheng W., Johnston S.A.;
RT   "The nucleic acid binding activity of bleomycin hydrolase is involved
RT   in bleomycin detoxification.";
RL   Mol. Cell. Biol. 18:3580-3585(1998).
RN   [12]
RP   FUNCTION.
RX   PubMed=12555812; DOI=10.1139/o02-167;
RA   Wang H., Ramotar D.;
RT   "Cellular resistance to bleomycin in Saccharomyces cerevisiae is not
RT   affected by changes in bleomycin hydrolase levels.";
RL   Biochem. Cell Biol. 80:789-796(2002).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [14]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [15]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 76625 / YPH499;
RX   PubMed=14576278; DOI=10.1073/pnas.2135385100;
RA   Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R.P.,
RA   Meyer H.E., Schoenfisch B., Perschil I., Chacinska A., Guiard B.,
RA   Rehling P., Pfanner N., Meisinger C.;
RT   "The proteome of Saccharomyces cerevisiae mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13207-13212(2003).
RN   [16]
RP   FUNCTION, AND MUTAGENESIS OF HIS-398.
RX   PubMed=16769724; DOI=10.1074/jbc.M603656200;
RA   Zimny J., Sikora M., Guranowski A., Jakubowski H.;
RT   "Protective mechanisms against homocysteine toxicity: the role of
RT   bleomycin hydrolase.";
RL   J. Biol. Chem. 281:22485-22492(2006).
RN   [17]
RP   ALTERNATIVE INITIATION.
RX   PubMed=17101987; DOI=10.1073/pnas.0605645103;
RA   Miura F., Kawaguchi N., Sese J., Toyoda A., Hattori M., Morishita S.,
RA   Ito T.;
RT   "A large-scale full-length cDNA analysis to explore the budding yeast
RT   transcriptome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17846-17851(2006).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 30-483 OF MUTANT ALA-102,
RP   AND MUTAGENESIS OF GLY-479.
RX   PubMed=9546396; DOI=10.1016/S0092-8674(00)81150-2;
RA   Zheng W., Johnston S.A., Joshua-Tor L.;
RT   "The unusual active site of Gal6/bleomycin hydrolase can act as a
RT   carboxypeptidase, aminopeptidase, and peptide ligase.";
RL   Cell 93:103-109(1998).
CC   -!- FUNCTION: The normal physiological role of the enzyme is unknown,
CC       but it is not essential for the viability of yeast cells. Has
CC       aminopeptidase activity, shortening substrate peptides
CC       sequentially by 1 amino acid. Has bleomycin hydrolase activity,
CC       which can protect the cell from the toxic effects of bleomycin.
CC       Has homocysteine-thiolactonase activity, protecting the cell
CC       against homocysteine toxicity. Acts as a repressor in the GAL4
CC       regulatory system, but this does not require either the peptidase
CC       or nucleic acid-binding activities. {ECO:0000269|PubMed:12555812,
CC       ECO:0000269|PubMed:16769724}.
CC   -!- CATALYTIC ACTIVITY: Inactivates bleomycin B2 (a cytotoxic
CC       glycometallopeptide) by hydrolysis of a carboxyamide bond of beta-
CC       aminoalanine, but also shows general aminopeptidase activity. The
CC       specificity varies somewhat with source, but amino acid arylamides
CC       of Met, Leu and Ala are preferred.
CC   -!- ENZYME REGULATION: Inhibited by E64, a specific inhibitor of
CC       cysteine proteases, N-ethylmaleimide, iodacetamide, and mercury
CC       and zinc ions. {ECO:0000269|PubMed:1400467,
CC       ECO:0000269|PubMed:8463237}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.8 uM for arginine-4-methyl-7-coumarylamide
CC         {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738,
CC         ECO:0000269|PubMed:8463237};
CC         KM=0.33 mM for glutamine-beta-naphthylamide
CC         {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738,
CC         ECO:0000269|PubMed:8463237};
CC         KM=228 uM for lysine-4-methyl-7-coumarylamide
CC         {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738,
CC         ECO:0000269|PubMed:8463237};
CC         Vmax=2.56 umol/h/mg enzyme for arginine-4-methyl-7-coumarylamide
CC         {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738,
CC         ECO:0000269|PubMed:8463237};
CC         Vmax=370 nmol/min/mg enzyme for glutamine-beta-naphthylamide
CC         {ECO:0000269|PubMed:1400467, ECO:0000269|PubMed:8063738,
CC         ECO:0000269|PubMed:8463237};
CC         Note=N-terminal acetylation of lysine-4-methyl-7-coumarylamide
CC         (Ac-Lys-AMC) reduces the catalytic efficiency 50-fold towards
CC         this substrate.;
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:1400467,
CC         ECO:0000269|PubMed:8063738, ECO:0000269|PubMed:8463237};
CC   -!- SUBUNIT: Homohexamer. Binds to nucleic acids. Binds single-
CC       stranded DNA and RNA with higher affinity than double-stranded
CC       DNA. {ECO:0000269|PubMed:7638617}.
CC   -!- SUBCELLULAR LOCATION: Isoform Cytoplasmic: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform Mitochondrial: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Mitochondrial;
CC         IsoId=Q01532-1; Sequence=Displayed;
CC       Name=Cytoplasmic;
CC         IsoId=Q01532-2; Sequence=VSP_026453;
CC         Note=Produced by alternative initiation at Met-30 of isoform
CC         Mitochondrial.;
CC   -!- PTM: The N-terminus of isoform Cytoplasmic is blocked.
CC   -!- MASS SPECTROMETRY: Mass=51830; Method=Electrospray; Range=31-482;
CC       Evidence={ECO:0000269|PubMed:9374524};
CC   -!- MISCELLANEOUS: Present with 521 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M97910; AAA35231.1; -; Genomic_DNA.
DR   EMBL; X69124; CAA48878.1; -; Genomic_DNA.
DR   EMBL; X68228; CAA48309.1; -; Genomic_DNA.
DR   EMBL; Z71515; CAA96144.1; -; Genomic_DNA.
DR   EMBL; Z69381; CAA93359.1; -; Genomic_DNA.
DR   EMBL; U74299; AAB18260.1; -; Genomic_DNA.
DR   EMBL; BK006947; DAA10320.1; -; Genomic_DNA.
DR   PIR; A46093; S25606.
DR   RefSeq; NP_014160.2; NM_001183077.1. [Q01532-2]
DR   PDB; 1A6R; X-ray; 2.05 A; A=32-483.
DR   PDB; 1GCB; X-ray; 2.20 A; A=30-483.
DR   PDB; 2DZY; X-ray; 2.57 A; A=30-482.
DR   PDB; 2DZZ; X-ray; 2.15 A; A=30-482.
DR   PDB; 2E00; X-ray; 2.00 A; A=30-482.
DR   PDB; 2E01; X-ray; 1.73 A; A=30-482.
DR   PDB; 2E02; X-ray; 2.20 A; A=30-482.
DR   PDB; 2E03; X-ray; 2.13 A; A=30-482.
DR   PDB; 3GCB; X-ray; 1.87 A; A=30-482.
DR   PDBsum; 1A6R; -.
DR   PDBsum; 1GCB; -.
DR   PDBsum; 2DZY; -.
DR   PDBsum; 2DZZ; -.
DR   PDBsum; 2E00; -.
DR   PDBsum; 2E01; -.
DR   PDBsum; 2E02; -.
DR   PDBsum; 2E03; -.
DR   PDBsum; 3GCB; -.
DR   ProteinModelPortal; Q01532; -.
DR   SMR; Q01532; 30-482.
DR   BioGrid; 35600; 15.
DR   DIP; DIP-2941N; -.
DR   IntAct; Q01532; 11.
DR   MINT; MINT-513897; -.
DR   MEROPS; C01.085; -.
DR   MaxQB; Q01532; -.
DR   PaxDb; Q01532; -.
DR   PeptideAtlas; Q01532; -.
DR   GeneID; 855482; -.
DR   KEGG; sce:YNL239W; -.
DR   CYGD; YNL239w; -.
DR   EuPathDB; FungiDB:YNL239W; -.
DR   SGD; S000005183; LAP3.
DR   eggNOG; COG3579; -.
DR   HOGENOM; HOG000064089; -.
DR   InParanoid; Q01532; -.
DR   KO; K01372; -.
DR   OMA; MNTQLRH; -.
DR   OrthoDB; EOG7X0VS5; -.
DR   BioCyc; YEAST:G3O-33237-MONOMER; -.
DR   BRENDA; 3.4.22.40; 984.
DR   Reactome; REACT_346191; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SABIO-RK; Q01532; -.
DR   EvolutionaryTrace; Q01532; -.
DR   NextBio; 979451; -.
DR   PRO; PR:Q01532; -.
DR   Proteomes; UP000002311; Chromosome XIV.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:SGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:SGD.
DR   GO; GO:0003729; F:mRNA binding; IDA:SGD.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:SGD.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:SGD.
DR   GO; GO:0043418; P:homocysteine catabolic process; IDA:SGD.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:SGD.
DR   GO; GO:0046677; P:response to antibiotic; IDA:SGD.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR004134; Peptidase_C1B.
DR   PANTHER; PTHR10363; PTHR10363; 1.
DR   Pfam; PF03051; Peptidase_C1_2; 1.
DR   PIRSF; PIRSF005700; PepC; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; DNA-binding; Hydrolase; Mitochondrion;
KW   Protease; Reference proteome; Thiol protease; Transit peptide.
FT   TRANSIT       1     30       Mitochondrion. {ECO:0000255}.
FT   CHAIN        31    482       Cysteine proteinase 1, mitochondrial.
FT                                /FTId=PRO_0000050554.
FT   PROPEP      483    483       Removed in mature form; by autocatalysis.
FT                                {ECO:0000269|PubMed:7638617}.
FT                                /FTId=PRO_0000292865.
FT   ACT_SITE    102    102
FT   ACT_SITE    398    398
FT   ACT_SITE    421    421
FT   VAR_SEQ       1     29       Missing (in isoform Cytoplasmic).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_026453.
FT   MUTAGEN     102    102       C->A: Abolishes peptidase activity, which
FT                                also hinders autocatalytic processing of
FT                                the enzyme to the mature form.
FT                                {ECO:0000269|PubMed:9374524}.
FT   MUTAGEN     271    274       KDKK->ADAA: In GAL6DB; disrupts nucleic
FT                                acid-binding activity, but retains normal
FT                                peptidase activity.
FT                                {ECO:0000269|PubMed:9374524}.
FT   MUTAGEN     398    398       H->A: Abolishes Hcy-thiolactonase
FT                                activity. {ECO:0000269|PubMed:16769724}.
FT   MUTAGEN     479    479       G->A: Results in the abnormal cleavage of
FT                                3 C-terminal residues instead of only 1
FT                                during autocatalytic processing.
FT                                {ECO:0000269|PubMed:9546396}.
FT   CONFLICT    187    187       I -> M (in Ref. 2; CAA48878).
FT                                {ECO:0000305}.
FT   HELIX        36     47       {ECO:0000244|PDB:2E01}.
FT   HELIX        50     59       {ECO:0000244|PDB:2E01}.
FT   HELIX        64     68       {ECO:0000244|PDB:2E01}.
FT   HELIX        71     77       {ECO:0000244|PDB:2E01}.
FT   STRAND       83     85       {ECO:0000244|PDB:2E01}.
FT   STRAND       98    100       {ECO:0000244|PDB:3GCB}.
FT   HELIX       102    118       {ECO:0000244|PDB:2E01}.
FT   HELIX       128    149       {ECO:0000244|PDB:2E01}.
FT   TURN        150    152       {ECO:0000244|PDB:2E01}.
FT   HELIX       158    165       {ECO:0000244|PDB:2E01}.
FT   HELIX       174    184       {ECO:0000244|PDB:2E01}.
FT   HELIX       189    191       {ECO:0000244|PDB:2E01}.
FT   HELIX       197    200       {ECO:0000244|PDB:2E01}.
FT   HELIX       203    226       {ECO:0000244|PDB:2E01}.
FT   STRAND      229    231       {ECO:0000244|PDB:1A6R}.
FT   HELIX       232    252       {ECO:0000244|PDB:2E01}.
FT   STRAND      264    269       {ECO:0000244|PDB:2E01}.
FT   STRAND      275    280       {ECO:0000244|PDB:2E01}.
FT   HELIX       282    288       {ECO:0000244|PDB:2E01}.
FT   STRAND      296    301       {ECO:0000244|PDB:2E01}.
FT   STRAND      311    314       {ECO:0000244|PDB:2E01}.
FT   STRAND      326    330       {ECO:0000244|PDB:2E01}.
FT   HELIX       333    345       {ECO:0000244|PDB:2E01}.
FT   STRAND      350    354       {ECO:0000244|PDB:2E01}.
FT   TURN        356    359       {ECO:0000244|PDB:2E01}.
FT   TURN        362    365       {ECO:0000244|PDB:2E01}.
FT   HELIX       374    377       {ECO:0000244|PDB:2E01}.
FT   HELIX       385    390       {ECO:0000244|PDB:2E01}.
FT   STRAND      398    407       {ECO:0000244|PDB:2E01}.
FT   TURN        409    411       {ECO:0000244|PDB:2E01}.
FT   STRAND      414    420       {ECO:0000244|PDB:2E01}.
FT   TURN        425    428       {ECO:0000244|PDB:2E03}.
FT   STRAND      432    436       {ECO:0000244|PDB:2E01}.
FT   HELIX       437    443       {ECO:0000244|PDB:2E01}.
FT   STRAND      444    450       {ECO:0000244|PDB:2E01}.
FT   HELIX       451    453       {ECO:0000244|PDB:2E01}.
FT   HELIX       456    463       {ECO:0000244|PDB:2E01}.
FT   STRAND      470    472       {ECO:0000244|PDB:2E01}.
FT   HELIX       477    479       {ECO:0000244|PDB:1A6R}.
SQ   SEQUENCE   483 AA;  55483 MW;  BF92A6049F98DD3D CRC64;
     MLPTSVSRSL YLKTFRSHLL RAPQIVLKRM SSSIDISKIN SWNKEFQSDL THQLATTVLK
     NYNADDALLN KTRLQKQDNR VFNTVVSTDS TPVTNQKSSG RCWLFAATNQ LRLNVLSELN
     LKEFELSQAY LFFYDKLEKA NYFLDQIVSS ADQDIDSRLV QYLLAAPTED GGQYSMFLNL
     VKKYGLIPKD LYGDLPYSTT ASRKWNSLLT TKLREFAETL RTALKERSAD DSIIVTLREQ
     MQREIFRLMS LFMDIPPVQP NEQFTWEYVD KDKKIHTIKS TPLEFASKYA KLDPSTPVSL
     INDPRHPYGK LIKIDRLGNV LGGDAVIYLN VDNETLSKLV VKRLQNNKAV FFGSHTPKFM
     DKKTGVMDIE LWNYPAIGYN LPQQKASRIR YHESLMTHAM LITGCHVDET SKLPLRYRVE
     NSWGKDSGKD GLYVMTQKYF EEYCFQIVVD INELPKELAS KFTSGKEEPI VLPIWDPMGA
     LAK
//
